Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy

被引:24
|
作者
White, Evan C. [1 ]
Murphy, James D. [1 ]
Chang, Daniel T. [1 ]
Koong, Albert C. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford Canc Inst, Stanford, CA 94305 USA
关键词
inflammatory bowel disease; toxicity; intensity-modulated radiation therapy (IMRT); RADIOTHERAPY; CANCER; SURGERY; HISTORY; TRIAL; RISK;
D O I
10.1097/COC.0000000000000010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective:To determine the short-term and long-term toxicity of abdominal and pelvic radiation therapy in a cohort of patients with inflammatory bowel disease (IBD). We hypothesize that with newer techniques, such as intensity-modulated radiation therapy (IMRT) and 3-dimensional conformal radiotherapy (3D-CRT), patients with IBD can safely undergo abdominal and pelvic radiation, with low risk for major acute or late toxicity.Materials and Methods:Nineteen consecutive patients with IBD (14 with ulcerative colitis, 5 with Crohn disease) who were treated with abdominal or pelvic external beam radiation therapy at Stanford University from 1997 to 2011 were identified. Fourteen patients were treated with IMRT and 5 were treated with 3D-CRT. Treated sites included prostate (n=8), gastric/esophageal (n=5), rectal/anal (n=3), and liver (n=3) tumors. Charts were reviewed and toxicity was graded according to the Common Terminology Criteria for Acute Events version 4.0. Median follow-up was 32.5 months. Fisher exact test was used to determine if any clinical and/or treatment factors were associated with toxicity outcomes.Results:Acute grade 3 toxicity occurred in 2 patients (11%). Late grade 3 toxicity occurred in 1 patient (6%). Acute grade 2 toxicity occurred in 28% of patients treated with IMRT versus 100% of patients treated with 3D-CRT (P=0.01). Acute grade 2 gastrointestinal toxicity was lower in patients treated with IMRT versus 3D-CRT (14% vs. 100%, respectively, P=0.002). Late grade 2 toxicity occurred in 21% of patients. Higher total dose (Gy) and biologically effective dose (Gy) were associated with increased rates of late grade 2 toxicity (P=0.02 and 0.03, respectively).Conclusions:These data suggest that select patients with IBD can safely undergo abdominal and pelvic radiation therapy. The use of IMRT was associated with decreased acute toxicity. Acute and late severe toxicity rates were low in this patient population with the use of modern radiation techniques.
引用
收藏
页码:564 / 569
页数:6
相关论文
共 50 条
  • [1] Gastrointestinal Toxicity in Patients With Inflammatory Bowel Disease Treated With Pelvic Radiation Therapy
    Glick, D.
    Warde, P.
    Su, J.
    Xu, W.
    Milosevic, M.
    Kim, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S388 - S389
  • [2] Safety of Pelvic and Abdominal Radiation Therapy for Patients With Inflammatory Bowel Disease: A Dosimetric Analysis of Acute Bowel Toxicity
    Hall, Jennifer C.
    Hall, Abbie K.
    Lozko, Yuliia
    Hui, Caressa
    Baniel, Claire C.
    Jackson, Scott
    Vitzthum, Lucas K.
    Chang, Daniel T.
    Rahimy, Elham
    Pollom, Erqi L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2025, 121 (02): : 442 - 451
  • [3] Acute and late toxicities in patients with inflammatory bowel disease (IBD) treated with radiation therapy (RT) for abdominal and pelvic neoplasms
    Ooi, CJ
    Willett, CG
    Zeitman, A
    Goldberg, S
    Sands, BE
    Podolsky, DK
    GASTROENTEROLOGY, 1999, 116 (04) : A797 - A797
  • [4] Toxicity with Contemporary Radiotherapy in Inflammatory Bowel Disease Patients Treated for Pelvic Malignancies
    Zinkin, J.
    Ziemba, Y.
    Zinkin, H. D.
    Akerman, M.
    Parashar, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E423 - E424
  • [5] Reduced Toxicity in Inflammatory Bowel Disease Patients Treated With Intensity Modulated Radiation Therapy (IMRT)
    White, E.
    Chang, D. T.
    Koong, A. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S355 - S355
  • [6] Toxicity and Efficacy Outcomes of Preoperative Pelvic Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
    Amarnath, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S161 - S161
  • [7] Acute and Chronic Complications After Abdominal/Pelvic Radiation in Patients With Inflammatory Bowel Disease
    Rhome, R. M.
    Axelrad, J.
    Itzkowitz, S.
    Harpaz, N.
    Colombel, J. F.
    Ang, C.
    Buckstein, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E492 - E492
  • [8] Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms
    Willett, CG
    Ooi, CJ
    Zietman, AL
    Menon, V
    Goldberg, S
    Sands, BE
    Podolsky, DK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (04): : 995 - 998
  • [9] Inflammatory bowel diseases activity in patients undergoing pelvic radiation therapy
    Annede, Pierre
    Seisen, Thomas
    Klotz, Caroline
    Mazeron, Renaud
    Maroun, Pierre
    Petit, Claire
    Deutsch, Eric
    Bossi, Alberto
    Haie-Meder, Christine
    Chargari, Cyrus
    Blanchard, Pierre
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (01) : 173 - 179
  • [10] Inflammatory bowel disease in patients with prostate cancer treated with radiation
    Gestaut, Matthew Maxwell
    Swanson, Gregory P.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)